e-learning
resources
Paris 2018
Monday, 17.09.2018
Pulmonary hypertension in lung diseases and the role of the right ventricle
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of suramin on cardiopulmonary capacity and pulmonary venous contraction in pulmonary arterial hypertension
M. Barros (Santiago, Chile), M. Fonseca (Santiago, Chile), M. Henriquez (Santiago, Chile)
Source:
International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Session:
Pulmonary hypertension in lung diseases and the role of the right ventricle
Session type:
Thematic Poster
Number:
3115
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Barros (Santiago, Chile), M. Fonseca (Santiago, Chile), M. Henriquez (Santiago, Chile). Effects of suramin on cardiopulmonary capacity and pulmonary venous contraction in pulmonary arterial hypertension. 3115
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension
Source: Eur Respir J 2010; 35: 6-8
Year: 2010
Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension
Source: Eur Respir J 2008; 32: 393-398
Year: 2008
Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension
Source: Eur Respir J 2014; 44: 704-713
Year: 2014
Intra-breath CO-diffusion and pulmonary blood flow at rest and during exercise in pulmonary arterial hypertension and pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 403s
Year: 2004
Apelin improves cardiac output in patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015
Endothelium in pulmonary arterial hypertension
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007
Impact of cyanosis on ventilatory kinetics during stairclimbing in pulmonary arterial hypertension
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021
Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension
Source: Eur Respir J 2010; 36: 1483-1485
Year: 2010
Arterial vascular volume changes with haemodynamics in schistosomiasis-associated pulmonary arterial hypertension
Source: Eur Respir J, 57 (5) 2003914; 10.1183/13993003.03914-2020
Year: 2021
The role of cardiopulmonary exercise tests in pulmonary arterial hypertension
Source: Eur Respir Rev, 27 (148) 170134; 10.1183/16000617.0134-2017
Year: 2018
Single arterial occlusion to locate resistance in patients with pulmonary hypertension
Source: Eur Respir J 2003; 21: 31-36
Year: 2003
Effect of normobaric hypoxia on pulmonary hemodynamics in patients with precapillary pulmonary hypertension
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Pulmonary arterial hypertension
Source: ISSN=ISSN 1810-6838, ISBN=, page=397
Year: 2007
Pulmonary arterial hypertension
Source: ISSN=ISSN 1810-6838, ISBN=, page=126
Year: 2005
Pulmonary arterial hypertension
Source: Breathe 2010; 6: 377-380
Year: 2010
Pulmonary arterial hypertension
Source: Eur Respir Monogr 2014; 66: 232-246
Year: 2014
Pulmonary arterial hypertension
Source: Eur Respir Monogr 2013; 62: 70-84
Year: 2013
Pulmonary arterial hypertension
Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases
Year: 2018
Elevated pulmonary capillary pressure in pulmonary arterial hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 3s
Year: 2001
Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept